DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slid 1.29% to $680.61 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.39% to 5,521.52 and Dow Jones Industrial Average falling 1.30% to 40,813.57.

This was the stock's third consecutive day of losses.

Regeneron Pharmaceuticals Inc. closed 43.81% below its 52-week high of $1,211.20, which the company achieved on August 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 0.04% to $312.64, Moderna Inc. $(MRNA)$ fell 2.03% to $34.30, and Gilead Sciences Inc. $(GILD)$ fell 0.56% to $113.35.

Trading volume (782,089) remained 131,895 below its 50-day average volume of 913,984.

Data source: Dow Jones Market Data, FactSet. Data compiled March 13, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 13, 2025 16:42 ET (20:42 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.